Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Goeppert

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Cancers|April 30, 2021
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder CancerThomas Albrecht, Fritz Brinkmann, Michael Albrecht, et al.
Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinomaBenjamin Goeppert, Lena Frauenschuh, Marcus Renner, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
Epigenetics|September 6, 2016
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaBenjamin Goeppert, Christina Ernst, Constance Baer, et al.
Annals of Surgery|June 25, 2021
Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable SurvivalChristine Tjaden, Ulf Hinz, Ulla Klaiber, et al.
Ebiomedicine|June 22, 2023
DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumoursMihnea P Dragomir, Teodor G Calina, Eilís Perez, et al.
BMC Cancer|May 2, 2021
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samplesKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
JHEP Reports : Innovation in Hepatology|October 4, 2023
JNKs protect from cholestatic liver disease progression by modulating Apelin signallingMohamed Ramadan Mohamed, Johannes Haybaeck, Hanghang Wu, et al.
The British Journal of Surgery|March 13, 2024
Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgeryAli Majlesara, Mohammad Golriz, Ali Ramouz, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Cancers|April 30, 2021
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder CancerThomas Albrecht, Fritz Brinkmann, Michael Albrecht, et al.
Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinomaBenjamin Goeppert, Lena Frauenschuh, Marcus Renner, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
Epigenetics|September 6, 2016
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaBenjamin Goeppert, Christina Ernst, Constance Baer, et al.
Annals of Surgery|June 25, 2021
Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable SurvivalChristine Tjaden, Ulf Hinz, Ulla Klaiber, et al.
Ebiomedicine|June 22, 2023
DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumoursMihnea P Dragomir, Teodor G Calina, Eilís Perez, et al.
BMC Cancer|May 2, 2021
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samplesKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
JHEP Reports : Innovation in Hepatology|October 4, 2023
JNKs protect from cholestatic liver disease progression by modulating Apelin signallingMohamed Ramadan Mohamed, Johannes Haybaeck, Hanghang Wu, et al.
The British Journal of Surgery|March 13, 2024
Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgeryAli Majlesara, Mohammad Golriz, Ali Ramouz, et al.
Pageof 14